JP2022513797A5 - - Google Patents
Info
- Publication number
- JP2022513797A5 JP2022513797A5 JP2021533528A JP2021533528A JP2022513797A5 JP 2022513797 A5 JP2022513797 A5 JP 2022513797A5 JP 2021533528 A JP2021533528 A JP 2021533528A JP 2021533528 A JP2021533528 A JP 2021533528A JP 2022513797 A5 JP2022513797 A5 JP 2022513797A5
- Authority
- JP
- Japan
- Prior art keywords
- orf1
- nucleic acid
- acid sequence
- sequence
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024075373A JP2024099834A (ja) | 2018-12-12 | 2024-05-07 | アネロソーム及び使用の方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862778841P | 2018-12-12 | 2018-12-12 | |
| US201862778866P | 2018-12-12 | 2018-12-12 | |
| US62/778,841 | 2018-12-12 | ||
| US62/778,866 | 2018-12-12 | ||
| PCT/US2019/065995 WO2020123816A2 (en) | 2018-12-12 | 2019-12-12 | Anellosomes and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024075373A Division JP2024099834A (ja) | 2018-12-12 | 2024-05-07 | アネロソーム及び使用の方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022513797A JP2022513797A (ja) | 2022-02-09 |
| JP2022513797A5 true JP2022513797A5 (enExample) | 2022-12-20 |
Family
ID=69165586
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533528A Withdrawn JP2022513797A (ja) | 2018-12-12 | 2019-12-12 | アネロソーム及び使用の方法 |
| JP2024075373A Pending JP2024099834A (ja) | 2018-12-12 | 2024-05-07 | アネロソーム及び使用の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024075373A Pending JP2024099834A (ja) | 2018-12-12 | 2024-05-07 | アネロソーム及び使用の方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220042042A1 (enExample) |
| EP (1) | EP3894570A2 (enExample) |
| JP (2) | JP2022513797A (enExample) |
| KR (1) | KR20210131310A (enExample) |
| CN (1) | CN113631716A (enExample) |
| AU (1) | AU2019397058A1 (enExample) |
| BR (1) | BR112021011124A2 (enExample) |
| CA (1) | CA3121528A1 (enExample) |
| IL (1) | IL283782A (enExample) |
| MX (1) | MX2021006977A (enExample) |
| WO (1) | WO2020123816A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3615659A4 (en) | 2017-04-28 | 2021-01-06 | Agrospheres, Inc. | COMPOSITIONS AND METHODS OF ENCAPSULATION AND SCALABLE DELIVERY OF AGROCHEMICALS |
| WO2018201160A1 (en) | 2017-04-28 | 2018-11-01 | Agrospheres, Inc. | Compositions and methods for enzyme immobilization |
| CA3073449A1 (en) | 2017-09-25 | 2019-03-28 | Agrospheres, Inc. | Compositions and methods for scalable production and delivery of biologicals |
| CA3119814A1 (en) * | 2018-12-12 | 2020-06-18 | Flagship Pioneering Innovations V, Inc. | Anellosomes for delivering protein replacement therapeutic modalities |
| AU2021288320A1 (en) * | 2020-06-12 | 2023-01-19 | Flagship Pioneering Innovations V, Inc. | Tandem anellovirus constructs |
| TW202235622A (zh) * | 2020-12-23 | 2022-09-16 | 美商旗艦先鋒創新公司 | 包裹rna之指環病毒(anellovirus)蛋白殼之活體外組裝 |
| EP4337235A4 (en) * | 2021-05-12 | 2025-07-02 | Flagship Pioneering Innovations V Inc | ANELLOVECTORS AND METHODS OF USE |
| TW202430215A (zh) | 2022-12-14 | 2024-08-01 | 美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 | 用於將治療劑遞送至骨之組成物和方法 |
| TW202529819A (zh) | 2023-10-13 | 2025-08-01 | 美商旗艦先鋒創新公司 | 組織特異性指環載體(anellovector)遞送 |
| WO2025160409A1 (en) | 2024-01-26 | 2025-07-31 | Flagship Pioneering Innovations V, Inc. | Viral vectors for modulating vegf function |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395472B1 (en) * | 1999-02-05 | 2002-05-28 | Abbott Laboratories | Methods of utilizing the TT virus |
| SG10201804975PA (en) * | 2013-12-12 | 2018-07-30 | Broad Inst Inc | Delivery, Use and Therapeutic Applications of the Crispr-Cas Systems and Compositions for HBV and Viral Diseases and Disorders |
| IL271275B1 (en) * | 2017-06-13 | 2026-04-01 | Flagship Pioneering Innovations V Inc | Preparations containing croons and their uses |
| CA3119814A1 (en) * | 2018-12-12 | 2020-06-18 | Flagship Pioneering Innovations V, Inc. | Anellosomes for delivering protein replacement therapeutic modalities |
| AU2019396520A1 (en) * | 2018-12-12 | 2021-05-27 | Flagship Pioneering Innovations V, Inc. | Anellosomes for delivering secreted therapeutic modalities |
| CN114127302A (zh) * | 2018-12-12 | 2022-03-01 | 旗舰先锋创新V股份有限公司 | 用于递送细胞内治疗方式的指环体 |
-
2019
- 2019-12-12 MX MX2021006977A patent/MX2021006977A/es unknown
- 2019-12-12 US US17/413,392 patent/US20220042042A1/en active Pending
- 2019-12-12 CA CA3121528A patent/CA3121528A1/en active Pending
- 2019-12-12 AU AU2019397058A patent/AU2019397058A1/en active Pending
- 2019-12-12 JP JP2021533528A patent/JP2022513797A/ja not_active Withdrawn
- 2019-12-12 EP EP19836738.5A patent/EP3894570A2/en active Pending
- 2019-12-12 BR BR112021011124A patent/BR112021011124A2/pt unknown
- 2019-12-12 WO PCT/US2019/065995 patent/WO2020123816A2/en not_active Ceased
- 2019-12-12 KR KR1020217021777A patent/KR20210131310A/ko not_active Ceased
- 2019-12-12 CN CN201980091082.6A patent/CN113631716A/zh active Pending
-
2021
- 2021-06-07 IL IL283782A patent/IL283782A/en unknown
-
2024
- 2024-05-07 JP JP2024075373A patent/JP2024099834A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022513797A5 (enExample) | ||
| JP2022512395A5 (enExample) | ||
| JP2020524993A5 (enExample) | ||
| KR101817482B1 (ko) | 캄필로박터 제주니 crispr/cas 시스템 유래 rgen을 이용한 유전체 교정 | |
| JP2022513459A5 (enExample) | ||
| KR102805002B1 (ko) | Pd-l1 발현의 감소를 위한 올리고뉴클레오티드 | |
| JP2022514501A5 (enExample) | ||
| KR20210131309A (ko) | 분비형 치료 양식을 운반하기 위한 아넬로좀 | |
| TW201945388A (zh) | 對b型肝炎病毒基因體中之識別序列具有特異性之最佳化之經工程化巨核酸酶 | |
| KR20210131310A (ko) | 아넬로좀 및 사용 방법 | |
| KR20210125990A (ko) | 단백질 대체 치료 양식을 운반하기 위한 아넬로좀 | |
| US7094399B2 (en) | Use of spliceosome mediated RNA trans-splicing to confer cell selective replication to adenoviruses | |
| KR20210131308A (ko) | 세포내 치료 양식을 운반하기 위한 아넬로좀 | |
| JP2024521894A (ja) | ＲＮＡ誘導型ＣａｓΩヌクレアーゼ並びに診断及び治療におけるその使用 | |
| CN110431230A (zh) | 慢病毒和非整合型慢病毒作为病毒载体实施crispr治疗 | |
| KR20010042848A (ko) | 인슐린유사 성장인자 ⅱ의 안티센스 올리고뉴클레오타이드서열 및 이를 이용한 세포성장 조절방법 | |
| CN102140473B (zh) | 抗肿瘤的核酸与多肽及其应用 | |
| EP4696777A1 (en) | Cas13 protein, and crispr-cas system and use thereof | |
| KR20250053925A (ko) | CRISPR-Cas13 시스템 및 이의 용도 | |
| KR20230036110A (ko) | 탠덤 아넬로바이러스 구축물 | |
| Su et al. | Identification of gene products suppressed by human immunodeficiency virus type 1 infection or gp120 exposure of primary human astrocytes by rapid subtraction hybridization | |
| CN114306367B (zh) | 一种含有C/EBPα-saRNA的组合物 | |
| CA2251818A1 (en) | Mammalian genes involved in viral infection and tumor suppression | |
| CN111518812B (zh) | 一种编辑绵羊FGF5基因实现选择性剪接的sgRNA、成套核酸分子和应用 | |
| CN101331231B (zh) | 用于rna治疗的肽核糖核酸缩合粒子的复合物及方法 |